Suki Funding: $165M Raised, Series D (2024)

Suki is a Healthtech company based in Los Altos, California. It has raised $165M in total funding. Latest round: Series D.

Suki funding overview

Suki is a Healthtech company based in Los Altos, California. Suki has raised $165M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series D announced in October 2024. The round record for Suki runs through 2024; nothing later has been disclosed. Investors on record include Hedosophia, Venrock, March Capital, Philips Ventures, Flare Capital, Breyer Capital and 1 others. 7 distinct backers are named across the disclosed rounds.

Suki at a glance

Total raised
$165M
Latest round
Series D
Latest round date
October 2024
Industry
Healthtech
Headquarters
Los Altos, California
Notable investors
Hedosophia, Venrock, March Capital, Philips Ventures, Flare Capital, Breyer Capital, inHealth Ventures

Frequently asked about Suki funding

How much has Suki raised?
Suki has raised $165M in total disclosed funding across the rounds on record.
Who has invested in Suki?
Hedosophia, Venrock, March Capital, Philips Ventures, Flare Capital, Breyer Capital are named among the investors backing Suki.
What was the latest Suki funding round?
The most recent disclosed round is a Series D, announced in October 2024.
Where is Suki based?
Suki is based in Los Altos, California.
What sector does Suki operate in?
Suki is tracked under Healthtech from Los Altos, California, with $165M in disclosed funding.
When did Suki last raise?
The last disclosed Suki round closed in October 2024 at Series D.

Every Suki figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare Healthtech companies in Los Altos at a similar stage.

Suki founders (1)

Companies related to Suki (40)

Browse related funding lists (7)

Company funding database · Investor directory · Founder database · Mega-rounds 2026